Autonomous Syncope Onset Prediction and Prevention

Syncope Clinical Trial

Official title:

Autonomous Syncope Onset Prediction and Prevention An Open-label, One-centre Pilot Study on Healthy Subjects With the Erigo Tilt Table

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02684539
• Other study ID #: EF1
• Status: Withdrawn
• Phase: N/A
• Start date: April 2014
• Est. completion date: December 2014

Study information

• Verified date: October 2019
• Source: Swiss Federal Institute of Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

syncope prediction on tilt table

Description:

A tilt table is used to provoke syncope. syncope prediction is achieved through sensor measurements (ECG, ICG, SpO2, breathing rate, BP, NIRS, GSR, oculography).

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 2014
• Est. primary completion date: December 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 49 Years

Eligibility

Inclusion Criteria:

• healthy

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Syncope

Intervention

Device:
• tilt table Erigo®
tilting table with onset of syncope

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Swiss Federal Institute of Technology	University of Zurich

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	clinical sign of syncope	as diagnosed by the medical staff	1 session of 90 minutes duration